Metabasis Therapeutics, Inc.
Records under this name other than the patents Metabasis Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Back to Metabasis Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,563,746 | Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 8,329,914 | Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 8,410,284 | Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 8,394,969 | Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 12,440,502 | Use of Thyroid Beta-Agonists Held by another company In force · Low confidence | In force | Low confidence | |
| US 7,582,758 | Lewis acid mediated synthesis of cyclic esters Term ended Term ended Nov 12, 2026 · USPTO record | Term ended | Term ended Nov 12, 2026 | USPTO record |
| US 7,829,552 | Phosphorus-containing thyromimetics Term ended Term ended Oct 20, 2026 · USPTO record | Term ended | Term ended Oct 20, 2026 | USPTO record |
| US 10,925,885 | Thyromimetics for the treatment of fatty liver diseases Term ended Term ended Jul 11, 2026 · USPTO record | Term ended | Term ended Jul 11, 2026 | USPTO record |
| US 7,666,855 | 2′-C-methyl nucleoside derivatives Term ended Term ended Nov 6, 2024 · USPTO record | Term ended | Term ended Nov 6, 2024 | USPTO record |
| US 10,807,946 | Antagonists of the glucagon receptor Lapsed on the fee record Ended Oct 20, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 20, 2024 | USPTO record |